The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid meeting on 12 November 2025.
All proposals on the agenda were adopted, cf. the notification of the Extraordinary General Meeting that was published on Oslo Stock Exchange on 22 October 2025. The complete minutes of the Extraordinary General Meeting are attached and are also available on https://lifecare.no/investor/governance/
About us
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40
Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42
This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication at 2025-11-12 20:34 CET.